C2Sense, Inc.

C2Sense, Inc. is an optical sensing company based in Watertown, Massachusetts, founded in 2013 as a spin-off from the MIT Department of Chemistry. The company focuses on developing innovative sensing technologies that integrate advancements in chemistry, machine vision, material science, and optics to deliver accurate diagnostics at low cost. C2Sense offers two main product platforms. The Halo Diagnostics Platform is a connected immunoassay reader that provides rapid diagnostics with near-PCR sensitivity. It features user-friendly hardware and cloud-based software, allowing healthcare providers to access real-time test results remotely. The company also provides supply chain and product quality sensing solutions through molecular additive tags that monitor product quality and authenticity, applicable to various products and packaging. C2Sense serves healthcare providers, patients, immunoassay test manufacturers, and supply chain stakeholders, ensuring rapid diagnostics and product integrity. The company employs around 29 people and has reported revenues of approximately $7 million. Its leadership team combines expertise in various fields to drive innovation and product development.

• Employees 12
• Founded 2013
• Annual Revenue $8000000
• Total Funding $3200000